Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 34
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 9
Results: 20
1
2
Pembrolizumab plus Lenvatinib Combination Receives Regular FDA Approval for Advanced Endometrial Carcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 34
- Publication type:
- Article
3
FDA Approves Avapritinib for Advanced Systemic Mastocytosis.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 32
- Publication type:
- Article
4
FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Patients with Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 32
- Publication type:
- Article
5
FDA Approves Keytruda for High-Risk, Early-Stage Triple-Negative Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 32
- Publication type:
- Article
6
Rylaze FDA Approved as Part of a Treatment Regimen for Leukemia or Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 31
- Publication type:
- Article
7
FDA Approves Rezurock for the Treatment of Chronic Graft-versus-Host Disease.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 31
- Publication type:
- Article
8
Treatment Patterns and Prescribing Practices Based on Real-World Data.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 28
- By:
- Publication type:
- Article
9
Assuming Leadership of an Oncology Practice Team: Strategies for Better Success.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 26
- By:
- Publication type:
- Article
10
Biden Jabs at Pharma: Drug prices are falling, but the President needs a foil for inflation.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 25
- Publication type:
- Article
11
Saliva Test Accurate in Detecting HPV-Associated Head and Neck Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 24
- By:
- Publication type:
- Article
12
Global Data Show Alcohol Use Linked with Substantial Cancer Burden.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 22
- Publication type:
- Article
13
Sacituzumab Govitecan Significantly Improves Progression-Free Survival in TNBC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 21
- Publication type:
- Article
14
Study Shows Increase in Biosimilar Use Among Oncology Providers.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 20
- By:
- Publication type:
- Article
15
Neoadjuvant Nivolumab plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 17
- By:
- Publication type:
- Article
16
Sotorasib Shows Encouraging Activity in Patients with NSCLC and KRAS p.G12C Mutation.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 14
- By:
- Publication type:
- Article
17
A Comforted Heart: An oncology psychotherapist's perspective on finding meaning and hope during illness and loss.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 11
- Publication type:
- Article
18
HER2CLIMB Trial Results Confirm Survival Benefit with Tucatinib in HER2-Positive Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 1
- By:
- Publication type:
- Article
19
End-of-Life Care: Moving Beyond Practical Needs of Patients to Emotional Needs of People: An Interview with Kelly Grosklags, LICSW, BCD, FAAGC.
- Published in:
- 2021
- By:
- Publication type:
- Interview
20
Balstilimab Shows Promising Activity in Advanced Cervical Cancer, Regardless of PD-1/PD-L1 Expression.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 1
- By:
- Publication type:
- Article